FDA Approves Zepbound for Sleep Apnea in Adults with Obesity
Salaar Shah The U.S. Food and Drug Administration today approved Zepbound (tripeptide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity. This is a first-of-its-kind drug…